The five-membered nitrogen plus heteroatom rings known as azolines or in their oxidised form as azoles are very common in natural products and drugs. The oxidation of thiazoline to thiazole in the cyanobactin class of natural products is one of several important transformations which is known to alter the biological properties of the compound. The ordering of the various chemical reactions that occur during cyanobactin biosynthesis is not fully understood. The structure of the flavin-dependent enzyme responsible for the oxidation of multiple thiazolines reveals it contains an additional domain that in other enzymes recognises linear peptides. We characterise the enzyme activity of the oxidase on two substrates -one with a peptide leader and one without. Kinetics and biophysics reveal that the leader on substrate is not recognised by the enzyme. The oxidase enzyme is faster on either substrate than the macrocyclase or protease in vitro. The enzyme has a preferred order of oxidation of multiple thiazolines in the same linear peptide.
Introduction
Cyclic peptides have come under intensive investigation in recent years due to the bioactivities they possess, including anticancer, 1 antibacterial 2 and immuno-suppressive. 3 Reduced structural flexibility 4 gives cyclic peptides higher receptor binding affinity than their linear counterparts through a lower entropic penalty upon binding. 5 Cyanobactins 6 are a class of macrocyclic compounds, produced by cyanobacteria, and often contain posttranslational modifications including five-membered rings (azolines and azoles 7 ) that are produced from cysteine, threonine or serines. 8 Thiazolines, methyloxazolines and oxazolines are made by a heterocyclase, and can undergo enzymatic oxidation to become thiazoles and (methyl)oxazoles, respectively. 9 Azoles are aromatic, chemically more stable, and conformationally different from azolines due to the flattening of the ring. 10 The oxidation status of thiazoline/oxazoline is known to alter the function of the parent macrocycles. 11 The most striking demonstration is an increase of two orders of magnitude in cytotoxicity against bladder carcinoma cells between lissoclinamides 4 and 5 ( Figure 1 ) which differ only in thiazoline vs thiazole. 12 Azol(ine)s are commonly found in ribosomally synthesized and posttranslationally modified peptides (RiPPs) of the thiazole/oxazole-modified microcins (TOMMs) class. 13 Microcin B17 is a classic TOMM peptide, and azoles are produced by the McbBCD complex which is comprised of a recognition domain (peptide clamp, also termed the RiPP recognition element, RRE) 14 , a heterocyclase (cyclodehydratase) and an oxidase (dehydrogenase). 15 BalhBCD, another TOMM biosynthetic enzyme, also operates as a tripartite complex. 16 In contrast, the cyanobactin oxidase does not appear to form a complex with the heterocyclase, which in cyanobactin biosynthetic pathways is found as a fusion of an RRE-containing domain and the YcaO (catalytic) domain. The oxidase is either fused with the macrocyclase enzyme and a domain of unknown function, or found as a standalone protein. In addition, the cyanobactin oxidases have two RREs at the N-terminus, shown by the crystal structure of ThcOx (Figure 2b ) from the cyanothecamide biosynthesis pathway. 17 The C-terminal domain shows sequence homology to other TOMM oxidases and binds flavin mononucleotide (FMN), identifying it as the catalytic domain. The functions of the RREs in ThcOx, which share high structural similarity with the leader-binding domain in LynD 18 ( Figure S1 ), are however poorly understood. The second of the two domains sits at the dimer with the clamping region hidden, whereas the clamp region of the N-terminal RRE is exposed and may participate in substrate binding ( Figure 2b Here we report the first biochemical characterisation of a cyanobactin-type oxidase. We showed that the oxidases ThcOx and ArtGox operate on leaderless and fulllength linear peptide substrates. We have determined that the reaction proceeds with an order where there are multiple thiazolines in the substrate, and that the order is preserved irrespective whether the leader peptide is present. Despite the presence of RRE, no interaction was found between the leader peptide and the oxidase. The N-terminal domains instead appear to maintain the structural integrity and consequently activity of the enzyme as a whole.
Materials and Methods
General methods. Unless specified, all chemicals were purchased from Sigma-Aldrich or Fisher Scientific. Oligonucleotides were purchased from ThermoFisher Scientific. Restriction enzymes were purchased from Promega. dNTP and DNA polymerase were purchased from EMD Millipore™ Novagen™ KOD Hot Start DNA Polymerase kit. DNA sequencing was performed by GATC. Peptides were purchased from Biosynthesis.
Cloning and overexpression. ThcOx (Cyanothece sp. PCC 7425, UniprotKB B8HTZ1) was expressed with an N-terminal Tobacco etch virus (TEV) protease-cleavable His6 tag followed by a four-glycine as previously described. 19 ArtGox (Arthrospira platensis, UniprotKB H1W8K1) 19 was cloned into a pEHISTEVSUMO vector, 20 and expressed with an N-terminal His6 tag followed by a SUMO tag and TEV protease cleavage site. ThcOx-Ox (residue 233-473 of ThcOx) and ThcOx-Ox2 (residue 203-473) were cloned from full length ThcOx into a pEHISTEV vector with a N terminal His6-tag and a TEV protease cleavage site. 20 All proteins were expressed in Escherichia coli BL21 (DE3) cells grown in autoinduction medium by Studier method for 48 hours at 20°C. 21 For ArtGox, ThcOx and variants, 50µM riboflavin was added to the expression media.
PatE3', PatE3KK and ThcE1 ( Figure S2 gives sequences) were cloned into a pBMS23CHIS vector 20 and expressed with a C-terminal non-cleavable His6 tag in E.coli BL21(DE3) cells. Starter cultures were grown in LB media at 37 °C, 200 rpm until the optical density at the wavelength of 600 nm reaches 0.6, and induced with 1 mM IPTG. Cells were further incubated at 37 °C, 200 rpm for 5 hours before harvesting by centrifugation at 4000 rpm for 15 min at 20 °C. u-13 C, 15 N-labelled and u-15 N-labelled PatE2K were expressed as previously described. 22 Purification of proteins and peptides. E. coli cells overexpressing ThcOx, ArtGox and ThcOx-Ox were resuspended in lysis buffer (150 mM NaCl, 20 mM Tris-HCL pH 8.0, 20 mM imidazole pH 8.0, 50 µM FMN, 3 mM 2-mercaptoethanol) plus EDTA-free protease-inhibitor tablets (Roche) and DNase at 0.4mg per gram of wet cell pellet. The resuspension was lysed by passing through a cell disruptor at 30 kpsi (Constant systems). The lysate was cleared by centrifugation (6,000 rpm, 4 °C, 20 min) and then loaded onto a Ni Sepharose 6 Fast Flow column (GE Healthcare) equilibrated with lysis buffer. The protein was eluted with elution buffer (150 mM NaCl, 20 mM Tris-HCL pH 8.0, 250 mM imidazole pH 8.0, 50 µM FMN, 3 mM 2-mercaptoethanol) and passed over a desalting column (16/10 Desalting, GE Healthcare) exchanging into the desalting buffer (100 mM NaCl, 20 mM Tris-HCl pH 8.0, 3 mM 2-mercaptoethanol, 50 µM FMN). TEV protease was added at a mass ratio of 1:10 and the protein was digested for 3 hours at 20 °C before being loaded onto a second nickel column pre-equilibrated with desalting buffer. The eluted protein was applied directly to an anion-exchange column (HisTrap Q Sepharose FF, GF Healthcare) where it was eluted with a 0.1 to 1 M NaCl gradient. The peak fraction was then concentrated to 7.5 ml (Vivaspin concentrators, 30 kDa MWCO) and applied onto a Superdex 200 gel filtration column (GE Healthcare) equilibrated with gel filtration buffer (150 mM NaCl, 20 mM HEPES pH 7.4, 1 mM TCEP). Heterocyclases LynD (UniprotKB A0YXD2), AcLynD and ThcOx -Ox
ThcOx -Ox2
Residue 233-473 a MicD (UniprotKB I4F6C3) were purified as previously described. 18, 19 Cells expressing precursor peptides were re-suspended in urea lysis buffer (8 M Urea, 500 mM NaCl, 20 mM Tris-HCL pH 8.0, 20 mM imidazole pH 8.0, 3 mM 2mercaptoethanol) and lysed by sonication then the lysate cleared by centrifugation at 19,000 rpm for 20 min at 20 °C. The supernatant was filtered through 5 µm and 0.8 µm filters before being loaded onto a Ni-Sepharose 6 FF column (GE Healthcare) pre-equilibrated with lysis buffer. Peptide was eluted with urea elution buffer (8 M Urea, 500 mM NaCl, 20 mM Tris-HCL pH 8.0, 250 mM imidazole pH 8.0, 3 mM 2-mercaptoethanol). The eluate was supplemented with 10 mM dithiothreitol (DTT) and incubated at 20 °C for 2 hours to reduce all the cysteines. PatE3' was subjected to size-exclusion chromatography (Superdex 75, GE Healthcare) in gel filtration buffer (150mM NaCl, 20mM HEPES). The integrity, identity and purity of the proteins and peptides was confirmed by SDS-PAGE and mass spectrometry.
Heterocyclisation and Proteolysis.
To produce substrates with thiazoline heterocycles for oxidation (Scheme S1), 100 µM PatE3' or ThcE1 was reacted with MicD (10 µM), in gel filtration buffer (150 mM NaCl, 20 mM HEPES, 1 mM TCEP) supplemented with MgCl2 (10 mM) and ATP (10 mM), at 27 °C for 16 hours. 15 N E2K (175µM) was reacted with LynD (5 µM), and PatE3KK was reacted with MicD (10 µM) for 16 h at room temperature, in 100 mM Tris pH 8.0 supplemented with 150 mM NaCl, 10 mM ATP, 10 mM MgCl2 and 5 mM DTT. The reaction mixtures were then loaded onto a Superdex 75 column (GE Healthcare), equilibrated in gel filtration buffer to separate MicD/ LynD and the heterocyclised material ( Figure S3 ). Heterocyclisation of these substrates was confirmed by MS ( Figure S4 , S6).
Where leaderless substrates were used, heterocyclised peptides were incubated with trypsin (1:100 mass ratio) at 20 °C for 16 hours to cleave the leader. In the case of PatE2K and PatE3', the trypsin-treated sample was loaded onto a Ni-Sepharose 6 FF column (GE Healthcare), pre-equilibrated with gel filtration buffer. The eluate was then passed through a desalting column (16/10 Desalting, GE Healthcare) into gel filtration buffer. Proteolysis was confirmed by MS ( Figure S5, S7 ). In the case of PatE3KK, trypsin was inactivated by heating the sample at 100 °C for 10 min, and no purification step was carried out. Finally, the chemically synthesized peptide ITACITFCAYD (Biosynthesis) was incubated with AcLynD (10 µM) in gel filtration buffer supplemented with 10 mM ATP and 10 mM MgCl2 for 16 h at 20 °C, prior to reaction with ThcOx and variants (10 µM each), without purification in between.
Oxidation reactions.
Various concentrations of enzymes and substrates were used as stated individually in the results section. ThcOx reactions were carried out in 100 mM HEPES pH 7.5, 150mM NaCl. ArtGox reactions were carried out in 100 mM Tris pH 8.0 supplemented with 150 mM NaCl and 2mM FMN.
Enzyme Kinetics. Steady-state kinetics were obtained using a commercial hydrogen peroxide assay kit (Abcam, ab102500). ThcOx (100 nM, Figure S8 ) and varying concentrations of heterocycle containing full-length and leaderless PatE3' or full-length ThcE1. The substrates were added to a Corning TM 96-well half area black flat bottom polystyrene microplate. In the presence of Horse Radish Peroxidase (HRP), the OxiRed probe produces a product with red fluorescent (Ex/ Em=535/587 nm) by reaction with H2O2, which is the other of azole formation (Scheme S2). Fluorescence was measured with a SpectraMax 2e microplate reader (Molecular Devices). All experiments were performed at 25 °C. Data were corrected for the auto-fluorescence of ThcOx and the substrate were used for background correction. Initial rates were plotted against substrate concentration and fitted to the Michaelis-Menton Equation (below) in Graphpad Prism. ThcOx-Ox was subjected to the size exclusion chromatography multi-angle light scattering (SEC-MALS) 23 for determination of molecular mass. Purified protein was loaded onto a GE Health Superdex 200 column, equilibrated in Gel filtration buffer (150mM NaCl, 10mM HEPES, 1mM TCEP), attached to the Wyatt Dawn Heleos II Multi-Angle Light Scattering detector and Wyatt Optilab T-rex Refractive Index detector. Protein elution peak was recorded by differential refractive index (dRI).
ThcOx-Ox was exchanged into circular dichroism buffer (500 mM sodium phosphate buffer pH 8.0, 200 mM NaF) and concentrated to a final concentration of 0.2 mg/ml. The circular dichroism signal was measured and recorded by a Bio-Logic Science Instrument MOS-500 Circular Dichroism Spectrometer. 1 H, 15 N HSQC spectra of full-length u-13 C, 15 N Pat-E2K were acquired on a Bruker AVANCE 500 MHz spectrometer equipped with a TXIz probe, controlled by Bruker Topspin software. A standard Bruker pulse sequence with Watergate water suppression was used with 8 transients at 2048×128 points with spectral resolutions of 9.8 Hz and 19.0 Hz in the direct ( 1 H) and indirect ( 15 N) dimensions, respectively. HSQC spectra were also recorded at 10 °C for the starting material, and 12 h and 60 h after the addition of 10 µM ArtGox. For sequential assignment, HNCACB spectra were acquired with 16 transients at 1024×50×128 points and spectral resolutions of 13.7 Hz, 44.6 Hz, and 157.1 Hz for the 1 H, 15 N and 13 C dimensions, respectively. CBCA(CO)NH spectra were acquired with 8 transients at 1024×50×114 points and spectral resolutions of 13.7 Hz, 44.6 Hz, and 176.4 Hz for the 1 H, 15 N and 13 
ively. Equivalent spectra were recorded for fully oxidized u-13 C, 15 N -PatE-2het (concentration 1.0 mM) and a sample where the enzymatic transformation was interrupted after 12 h by gel filtration on a Superdex S75 column (GE Healthcare) in heterocyclisation buffer supplemented with 5 mM FMN, thus allowing assignment of the reaction intermediate.
NMR experiments with the leaderless substrate were performed at 20 °C on a Bruker Ascend 700 MHz spectrometer equipped with a Prodigy TCI probe, controlled by Bruker Topspin software. For oxidation monitoring, 0.2 M cleaved peptide (see Preparation of Leaderless Substrate) was reacted with 10 µM ArtGox in 10 mM HEPES pH 7.4, 150 mM NaCl, 5 mM FMN and 5% D2O at 20 °C. 1 H, 15 N HSQC spectra were recorded before the addition of enzyme, 5 min and 20 min afterwards, and then every 30 min. Six transients were recorded at 1536×80 points with spectral resolutions of 12.8 Hz and 26.6 Hz in the direct ( 1 H) and indirect ( 15 N) dimensions, respectively. 1 H, 15 N HSQC spectra were recorded at 10 °C for the unreacted substrate and the final product. Sequential assignment of the full-length peptide was transferred to the 1 H, 15 N HSQC spectrum at 10 °C and then to the corresponding spectrum at 20 °C. Raw spectral data were processed by Topspin and analysed with CCPN Analysis 2. 21
Results

The Cyanobactin Oxidase operates on both full length and 'leaderless' substrates but is faster on the latter.
The presence of RRE in the cyanobactin oxidase, along with the fact that crystals were only obtained when the peptide NILPQQGQPVIR was added 17 , led to the hypothesis that parts of the leader peptide are involved in enzyme-substrate interaction. We predicted inactivity or reduced activity against leaderless peptides would be observed if the leader was important. ArtGox, previously been shown to oxidise thiazolines in fulllength (leader-containing) peptides, 19 was reacted with the four heterocycle containing peptide IT het AC het IT het -FC het AYDGEK (Scheme S1). The loss of 4 Da in ESI-MS ( Figure S9 ) demonstrated that two oxidation events haven taken place. Increasing the enzyme concentration to 50 µM (100 µM substrate) induced a further 2 Da mass loss ( Figure S9 ), corresponding to the formation of one methyloxazole which is not found in arthrospiramides, 19 suggesting oxazoline oxidation is kinetically hindered. Steady-state kinetics of ThcOx were carried out using full-length and trypsin-cleaved (leaderless) PatE3' that have been heterocyclised by MicD (Figure 3 , Table 1 ). We observed a seven-fold increase in kcat and a 50-fold increase in kcat/Km when the leaderless peptide as opposed to the full-length substrate was used. As the leader sequence of PatE3' is similar but not identical ( Figure S2 ) to that of ThcE, we tested the activity of ThcOx against one of its native substrates, ThcE1. Catalytic activity towards this substrate was similar with that to PatE3' confirming the leader does not accelerate catalytic activity. Table 1 . Table 1 Catalytic parameters obtained from steady-state kinetic studies of ThcOx. 1 H, 15 N-HSQC NMR spectroscopy was employed to investigate the oxidation order of doubly heterocyclised leaderless PatE2K (Figure 4 ). Heterocyclised cysteines C47 and C51 were not observed in the HSQC spectra, due to the loss of their amide protons, oxidation however alters the chemical environment of neighbouring residues A46, I48, T49, F50, A52, Y53, D54 and G55. Spectra were recorded before the addition of ArtGox, and at regular intervals afterwards. At 20 °C, the first oxidation at C47 happened rapidly after the addition of enzyme, and completed within 20 min, as demonstrated by shifting of the cross-peaks assigned to A46, I48, T49 and F50. The second oxidation step was slower and chemical shift changes corresponding to it (changes in F50, A52, Y53, D54 and G55) only became visible after 1 h of reaction. The second reaction was complete within 16 h yielding the final product (Figure 4) . The same N-C order of oxidation was shown when ArtGox was reacted with full-length PatE2K (Figure S10, S11) . The consistency indicates that the reaction order is an intrinsic property of ArtGox and the core substrate sequence. Consistent with the kinetic assays ( Figure 3, Table 1 ), the reaction was clearly slower with the full-length substrate, with the first step taking nearly 12 h and complete oxidation taking 60 h. 15 N-HSQC spectra were recorded for doubly heterocyclised, leaderless PatE2K (black), and after it was reacted with ArtGox for 20 min (blue) and 16 h (red). Cross-peaks are annotated with their residue sequences as of the full-length substrate; the colour of a label corresponds to the spectrum where the cross-peak it designates first appears. Note the cross-peaks for A46 and G55 after 20 min and 16 h are aliased in the 15N dimension; the actual 15N chemical shift for these signals is 133.8 ppm and 109.3 ppm, respectively.
Oxidation Proceeds in a Defined N-to-C Order
N-terminal Domain Maintains Structural Integrity and Enzyme Activity
As full-length peptides were worse substrates of the oxidase than their leaderless counterparts, we sought to determine if leader peptide binds in a way that reduces enzyme activity. PatE3' and ThcE1 that had not been heterocyclised were used to probe the binding between the leader peptide and ThcOx. However, binding with either peptide was not observed via isothermal titration calorimetry ( Figure 5 ), suggesting that a heterocyclised core peptide alone controls the enzyme-substrate interaction. In addition, we were unable to obtain a complex structure of ThcOx with any part of the leader peptide bound by crystallography. We tested if the C-terminal domain (homologous to other TOMM oxidases) alone was sufficient for enzymatic activity. The truncated oxidase domain ThcOx-Ox2 (residue 203-473) was cloned and expressed, but it was insoluble. ThcOx-Ox (residue 233-473) was then produced ( Figure S12) , and purified as a colourless protein, in contrast with yellow colour of native ThcOx, which was attributed to its co-factor FMN. The activity of ThcOx-ox was tested against ITAC Het -ITFC Het AYD, with native ThcOx as control. Whilst the native enzyme (10 µM) introduced a 4 Da mass loss in the peptide (Figure 6d ), ThcOx-Ox of the same concentration showed no activity (Figure 6b ). Even with external FMN supplementation ( Figure 6c ) the truncated enzyme was still unable to oxidise the thiazolines within the timescale of the experiment (16 h). The inability of exogenous FMN to rescue the reaction prompted us to think that the truncated enzyme could be unfolded or misfolded, and we therefore determined the secondary and quaternary structure of the protein with biophysical techniques. Purified ThcOx-Ox (molecular weight 27k-Da) was subjected to SEC-MALS which gives a solution mass of 54 kDa (Figure 7a ), consistent with that of a dimer. Circular dichroism (Figure 7b ) suggested there are 30% α-helices and 20% β-sheets in the protein, similar to the 29% α-helices and 22% β-sheets among residue 233-473 shown in the crystal structure of ThcOx. Taken together, we conclude that ThcOx-Ox is folded correctly overall, but FMN binding was disrupted by the truncation. 
Discussion
The cyanobactin oxidase is a fusion between two vestigial RREs 14 and an FMN-dependent oxidase domain that shows moderate sequence homology to other characterized TOMM oxidases (e.g. McbC and BalhB). 15, 16 The vestigial RREs of ThcOx each possess the characteristic structure 19 of three alpha helices and three beta strands. McbC and BalhB both form part of a heterocyclase-oxidase complex in conjunction with an RRE-containing protein and a YcaO (heterocyclisation) protein.
The RRE has been found with a variety of activities MccB (an adenylating enzyme in Trojan horse antibiotic microcin C7 biosynthesis pathway, pdb: 3H9J), LynD (a heterocyclase in aestuaramide pathway, pdb: 4V1T) and NisB (a dehydratase in lantibiotic nisin, pdb: 4WD9). 14 In many enzymes, the RiPP domain was found to be able to bind leader peptide. Since the structure of ThcOx showed it had two vestigial RREs fused to an oxidase domain (B protein), we wished to investigate their role. Steady-state kinetics and NMR both show that oxidase is faster and more efficient in the absence of the leader peptide on the substrate. We were unable to detect any binding of the leader to ThcOx. Our NMR results showed that the oxidase reaction proceeds with an N to C order, opposite to that demonstrated by the cyanobactin heterocyclase TruD 22 . Moreover, since the order is not dependent upon the leader, it is therefore a feature of the core sequence and enzyme. The vestigial RREs in the oxidase do not act as a clamp for the oxidase but their loss seems to destabilise the enzyme.
In the processing of cyanobactin precursor peptide in vivo, the PatA protease cleaves off the leader. The lack of leader binding by the oxidase (as well as the inefficient processing of such a leader substrate) would suggest that heterocyclisation is followed by protease cleavage (a slow reaction in vitro), then oxidation which we have shown is much more rapid than macrocyclisation in vitro. 25, 26 Quite why the organism uses rates to regulate production is unclear, but we note the frequent presence of epimerised amino acids adjacent to the thiazoles in the many cyanobactins. Since epimerisation has been assumed to be spontaneous for thiazolines, it may be the slow enzyme rate may be related to this. The inactivity of the RREs was an unexpected result given that they are found as part of the oxidase in many cyanobactin biosynthetic pathways, and cautions against automatic as-signment of function. A similar founding was shown by the recent structural elucidation of the structure peptide-modifying radical SAM enzyme SuiB, which contains an N-terminal RRE, but uses a different site for leader peptide binding.
From a biotechnological perspective, the oxidase is a versatile enzyme capable of using a range of different substrates, including linear and macrocyclic peptides. 20 Its functional independence of the leader means it could be incorporated into the semi-synthetic approach toward patellamide-like peptides described in previous studies. 18, 19 ASSOCIATED CONTENT Supporting Information. Figure S1 to S12, Schemes S1 and S2 and Tables S1 and S2 are supplied in the accompany supporting information. The Supporting Information is available free of charge on the ACS Publications website. 
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